Precursors to Cervical Cancer: What Are CIN1, CIN2, and CIN3, and Can Progression Be Prevented?

Cervical cancer is one of the most common cancers among women worldwide. It is treatable when detected early but can cause serious health problems if diagnosed late. The 2020 Cancer Statistics for Turkey report approximately 2,532 women diagnosed with cervical cancer and 1,245 deaths from the disease each year. These figures make cervical cancer the third most common gynecological cancer among women in Turkey in terms of both incidence and mortality.

Cervical cancer develops particularly in association with human papillomavirus (HPV) infection, as a result of changes in the cervical cells. HPV infection is widespread and is often cleared by the body's immune system; however, virus-induced cellular changes can eventually lead to uncontrolled cell growth and cancer.

Early cervical cancer often causes no symptoms, increasing the importance of regular cancer screening and early diagnosis.

What Are Precancerous Changes in the Cervix?

Atypical cellular changes occur in the cervix before cervical cancer develops. These are considered precursors to cervical cancer and are generally called cervical intraepithelial neoplasia (CIN) in medical literature. The term refers to precancerous changes in cervical cells.

CIN= Cervical Intraepithelial Neoplasia

Not everyone with atypical cervical cells develops cervical cancer, and these cells often disappear on their own. Nevertheless, abnormal cells can sometimes develop into cervical cancer.

What Is Cervical Intraepithelial Neoplasia (CIN)?

Cervical intraepithelial neoplasia (CIN) describes precancerous patterns of atypical cell growth in the cervix. These cellular changes are not cancer, but may develop into cervical cancer if untreated.

CIN is classified as CIN1, CIN2, or CIN3 according to the severity of the cellular abnormalities:

• CIN1 (Mild Dysplasia): Mild cellular abnormalities that usually require no treatment because the body can often resolve these minor changes on its own.
• CIN2 and CIN3 (Moderate to Severe Dysplasia): More serious cellular abnormalities. CIN2 and CIN3 may require treatment if they progress or do not resolve spontaneously within 1-2 years. CIN3 is particularly likely to be treated because of its high risk of progressing to cervical cancer.

What Are the Risks of CIN1-2-3 Progressing to Cervical Cancer?

The risk of CIN progressing to cervical cancer increases with the CIN grade.

• CIN1: Also called mild dysplasia, it generally carries a low risk. The risk of CIN1 progressing to cervical cancer is low, usually between 1% and 5%. Most CIN1 cases resolve spontaneously and do not progress.
• CIN2: Moderate dysplasia, with a higher risk of progression. Studies put the risk of CIN2 progressing to cervical cancer between 5% and 10%. CIN2 is generally monitored more closely and sometimes treated.
• CIN3: Severe dysplasia or carcinoma in situ (CIS), with the highest risk of progression. The risk of CIN3 developing into cervical cancer ranges from 30% to 50% and generally requires active treatment.

These risk estimates come from observations in the general population and may vary with individual risk factors, the presence and duration of HPV infection, immune system status, and other environmental or genetic factors. Women diagnosed with CIN therefore need regular medical follow-up and treatment when necessary.

Symptoms Before Cervical Cancer

Precancerous cervical changes usually cause no obvious symptoms. Symptoms of early cervical cancer may, however, include:

• Abnormal vaginal bleeding
• Increased vaginal discharge
• Pain during sexual intercourse
• Menstrual changes
• Pelvic pain (pain in the groin region)

These symptoms are not specific to cervical cancer and may also indicate endometriosis, fibroids, or an infection. Anyone experiencing these symptoms should therefore consult a health professional for further assessment.

Risk Factors for Precancerous Cervical Changes

HPV (human papillomavirus) is responsible for almost all cervical cancers. It is among the most common sexually transmitted infections, and a large proportion of adults worldwide become infected at some point in their lives. Its prevalence varies with age, sexual activity, number of sexual partners, geography, and other factors. Some studies suggest that approximately 80% of sexually active individuals are exposed to HPV at some point.

Recommended for adolescents and young adults, the HPV vaccine protects against the most common cancer-causing HPV types.

Other factors that may increase the risk of cervical cancer and precancerous conditions include:

• A weakened immune system
• Smoking
• Certain sexually transmitted infections (STIs)
• A family history of cervical cancer
• Multiple pregnancies
• Long-term oral contraceptive use
• Multiple sexual partners

Diagnosis and Treatment of Precancerous Cervical Conditions

Diagnosing Precancerous Cervical Conditions: A Step-by-Step Process

Modern medical techniques allow precancerous cervical conditions to be detected early. If a Pap smear or HPV test shows atypical findings, health professionals recommend colposcopy for further assessment. Colposcopy uses a special microscope called a colposcope to examine the cervix in detail. Cervical biopsy samples from atypical-looking areas are examined to grade cellular changes and determine whether treatment is needed.

Can CIN Lesions Be Prevented From Becoming Cancer? Treatment

Scientific and clinical research has focused primarily on detecting CIN early, developing effective treatments, and reducing risk factors.

Important strategies and research aimed at preventing CIN lesions from progressing to cancer are presented below:

1. HPV Vaccination

• HPV Vaccine Research: HPV infection, particularly with high-risk HPV types, is known to be the main cause of CIN and ultimately cervical cancer. HPV vaccines (for example, Gardasil and Cervarix) can significantly reduce the risk of CIN and cervical cancer by protecting against these high-risk types. International studies and clinical trials have shown that HPV vaccination effectively prevents cervical precursors and cancer cases. Vaccines can therefore be given and remain effective even after CIN develops.

2. Regular Screening and Colposcopy

• Pap Smear and HPV Testing: Regular cervical screening (Pap smear tests) and HPV testing play a vital role in detecting CIN lesions early. Identifying early CIN allows necessary interventions and prevention of progression to cancer.
• Colposcopy and Biopsy: Colposcopy and, when necessary, biopsy are important in patients with abnormal Pap smear or HPV results to determine the CIN grade and plan appropriate treatment.

3. Surgical Interventions and Treatments

• LEEP and Conization: Surgical interventions such as loop electrosurgical excision procedure (LEEP) or conization are widely used for higher-grade lesions such as CIN2 and CIN3. They effectively remove abnormal cells and help prevent progression to cancer. Other options include cryotherapy (cold treatment) and cone biopsy (cervical conization) . These methods effectively destroy abnormal cells and help prevent cervical cancer. Both approaches treat precancerous cervical changes through early intervention, substantially reducing cancer risk.

4. Lifestyle Changes and Risk Reduction

• Not Smoking and Adopting a Healthy Lifestyle: Smoking is known to increase the risk of CIN and cervical cancer. Adopting a healthy lifestyle and avoiding smoking may reduce the risk.

5. Scientific Research and Clinical Studies

• New Treatments: Research into new methods and drugs for CIN treatment continues. New strategies, such as immunotherapy and HPV-targeted antiviral treatments, are being investigated in clinical trials and research projects.

Preventing CIN lesions from progressing to cancer requires a comprehensive approach. HPV vaccination, regular screening, early diagnosis, effective treatment, and lifestyle changes are important components. Recent advances in this field: cervical cancer prevention strategies...

Summary

Abnormal Pap smear or HPV results indicate that a person may have precancerous cervical changes, highlighting the need for follow-up investigations and possible treatment. Early diagnosis and treatment are crucial for managing these conditions and improving overall health.